Committee header
PHARMACEUTICAL RESEARCH AND MANUFACTURERS ASSOCIATION OF AMERICA PAC
Active cycles
2005-20062007-20082009-20102011-20122013-20142015-20162017-20182019-20202021-20222023-20242025-2026
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2021-2022 cycle
- Raised
- $405,000Dated receipts + reported unitemized intervals
- Spent
- $390,900
- Net activity
- $14,100
Receipt coverage evidence (85 components)
- Filing 2566102, amendment 0, F497P2: Receipt date 2021-03-12; $4,000.00; s497_not_received
- Filing 2659453, amendment 0, F497P2: Receipt date 2022-03-22; $1,100.00; s497_not_received
- Filing 2659453, amendment 0, F497P2: Receipt date 2022-03-22; $2,400.00; s497_not_received
- Filing 2659453, amendment 0, F497P2: Receipt date 2022-03-22; $4,900.00; s497_not_received
- Filing 2661989, amendment 0, F497P2: Receipt date 2022-03-31; $2,300.00; s497_not_received
- Filing 2661989, amendment 0, F497P2: Receipt date 2022-03-31; $2,500.00; s497_not_received
- Filing 2661989, amendment 0, F497P2: Receipt date 2022-03-31; $3,000.00; s497_not_received
- Filing 2661989, amendment 0, F497P2: Receipt date 2022-03-31; $2,500.00; s497_not_received
- Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $2,400.00; s497_not_received
- Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $4,900.00; s497_not_received
- Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $2,500.00; s497_not_received
- Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $2,000.00; s497_not_received
- Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $100.00; s497_not_received
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 100% of dated attributable receipts.
Dominant category: Operations at 100% of spending.
Funding distribution
$5,000+
Count: 50
Share: 100%
Amount: $405,000
| Contribution bucket | Count | Amount | Share of dated receipts |
|---|
| $5,000+ |
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings page Filing 2664994, amendment 0, F497P2: Receipt date 2022-04-11; $3,000.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,000.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $600.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,300.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,000.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,000.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $200.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,500.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $1,900.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $4,900.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,000.00; s497_not_receivedFiling 2679467, amendment 0, F497P2: Receipt date 2022-05-05; $2,500.00; s497_not_receivedFiling 2681586, amendment 0, F497P2: Receipt date 2022-05-11; $2,000.00; s497_not_receivedFiling 2681586, amendment 0, F497P2: Receipt date 2022-05-11; $1,500.00; s497_not_receivedFiling 2681586, amendment 0, F497P2: Receipt date 2022-05-11; $100.00; s497_not_receivedFiling 2681586, amendment 0, F497P2: Receipt date 2022-05-11; $2,000.00; s497_not_receivedFiling 2681586, amendment 0, F497P2: Receipt date 2022-05-11; $1,900.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $900.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $2,500.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $2,500.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $2,500.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $3,100.00; s497_not_receivedFiling 2689240, amendment 0, F497P2: Receipt date 2022-06-01; $4,900.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $3,000.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $2,000.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $2,000.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $1,500.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $2,500.00; s497_not_receivedFiling 2713559, amendment 0, F497P2: Receipt date 2022-08-23; $2,000.00; s497_not_receivedFiling 2714513, amendment 0, F497P2: Receipt date 2022-08-25; $1,500.00; s497_not_receivedFiling 2714513, amendment 0, F497P2: Receipt date 2022-08-25; $2,500.00; s497_not_receivedFiling 2714513, amendment 0, F497P2: Receipt date 2022-08-25; $2,500.00; s497_not_receivedFiling 2714513, amendment 0, F497P2: Receipt date 2022-08-25; $3,000.00; s497_not_receivedFiling 2726673, amendment 0, F497P2: Receipt date 2022-09-30; $2,500.00; s497_not_receivedFiling 2726673, amendment 0, F497P2: Receipt date 2022-09-30; $4,000.00; s497_not_receivedFiling 2726673, amendment 0, F497P2: Receipt date 2022-09-30; $2,500.00; s497_not_receivedFiling 2726673, amendment 0, F497P2: Receipt date 2022-09-30; $2,500.00; s497_not_receivedFiling 2726673, amendment 0, F497P2: Receipt date 2022-09-30; $2,500.00; s497_not_receivedFiling 2729471, amendment 0, F497P2: Receipt date 2022-10-06; $1,900.00; s497_not_receivedFiling 2729471, amendment 0, F497P2: Receipt date 2022-10-06; $3,500.00; s497_not_receivedFiling 2729471, amendment 0, F497P2: Receipt date 2022-10-06; $1,300.00; s497_not_receivedFiling 2729471, amendment 0, F497P2: Receipt date 2022-10-06; $1,900.00; s497_not_receivedFiling 2729471, amendment 0, F497P2: Receipt date 2022-10-06; $2,400.00; s497_not_receivedFiling 2752982, amendment 0, F497P2: Receipt date 2022-11-07; $1,800.00; s497_not_receivedFiling 2576779, amendment 0, F460: 2021-01-01 – 2021-03-31; amount unknown; accepted · whole interval in windowFiling 2594309, amendment 0, F460: 2021-04-01 – 2021-06-30; amount unknown; accepted · whole interval in windowFiling 2615679, amendment 0, F460: 2021-07-01 – 2021-09-30; amount unknown; accepted · whole interval in windowFiling 2635087, amendment 0, F460: 2021-10-01 – 2021-12-31; amount unknown; accepted · whole interval in windowFiling 2670838, amendment 0, F460: 2022-01-01 – 2022-04-23; amount unknown; accepted · whole interval in windowFiling 2685917, amendment 0, F460: 2022-04-24 – 2022-05-21; amount unknown; accepted · whole interval in windowFiling 2698012, amendment 0, F460: 2022-05-22 – 2022-06-30; amount unknown; accepted · whole interval in windowFiling 2725826, amendment 0, F460: 2022-07-01 – 2022-09-24; amount unknown; accepted · whole interval in windowFiling 2742680, amendment 0, F460: 2022-09-25 – 2022-10-22; amount unknown; accepted · whole interval in windowFiling 2777581, amendment 0, F460: 2022-10-23 – 2022-12-31; amount unknown; accepted · whole interval in windowFiling 2576779, amendment 0, A: 2021-01-01 – 2021-03-31; $0.00; accepted · whole interval in windowFiling 2594309, amendment 0, A: 2021-04-01 – 2021-06-30; $0.00; accepted · whole interval in windowFiling 2615679, amendment 0, C: 2021-07-01 – 2021-09-30; $0.00; accepted · whole interval in windowFiling 2615679, amendment 0, A: 2021-07-01 – 2021-09-30; $0.00; accepted · whole interval in windowFiling 2635087, amendment 0, A: 2021-10-01 – 2021-12-31; $0.00; accepted · whole interval in windowFiling 2635087, amendment 0, C: 2021-10-01 – 2021-12-31; $0.00; accepted · whole interval in windowFiling 2670838, amendment 0, C: 2022-01-01 – 2022-04-23; $0.00; accepted · whole interval in windowFiling 2670838, amendment 0, A: 2022-01-01 – 2022-04-23; $0.00; accepted · whole interval in windowFiling 2685917, amendment 0, C: 2022-04-24 – 2022-05-21; $0.00; accepted · whole interval in windowFiling 2685917, amendment 0, A: 2022-04-24 – 2022-05-21; $0.00; accepted · whole interval in windowFiling 2698012, amendment 0, C: 2022-05-22 – 2022-06-30; $0.00; accepted · whole interval in windowFiling 2698012, amendment 0, A: 2022-05-22 – 2022-06-30; $0.00; accepted · whole interval in windowFiling 2725826, amendment 0, C: 2022-07-01 – 2022-09-24; $0.00; accepted · whole interval in windowFiling 2725826, amendment 0, A: 2022-07-01 – 2022-09-24; $0.00; accepted · whole interval in windowFiling 2742680, amendment 0, A: 2022-09-25 – 2022-10-22; $0.00; accepted · whole interval in windowFiling 2742680, amendment 0, C: 2022-09-25 – 2022-10-22; $0.00; accepted · whole interval in windowFiling 2777581, amendment 0, C: 2022-10-23 – 2022-12-31; $0.00; accepted · whole interval in windowFiling 2777581, amendment 0, A: 2022-10-23 – 2022-12-31; $0.00; accepted · whole interval in windowLarge-donor funded, Non-media-led spender, Active in 2021-2022 cycle.
Money over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
ContributionsExpenditures
Mar 2021Sep 2021May 2022Nov 2022
Spending categories
Operations
Amount: $390,900
Share: 100%
| Category | Amount | Share of spent |
|---|
| Operations | $390,900 | 100% |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS ASSOCIATION OF AMERICA PAC | PubSys CalAccessPanel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|
| ABBVIE | $16,200 | 4% | 2 | May 10, 2022 |
| ALKERMES, INC. | $16,200 | 4% | 2 | Jul 11, 2022 |
| AMGEN, INC. | $16,200 | 4% | 2 | Jul 11, 2022 |
| ASTELLAS PHARMA US, INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| BAYER US, LLC(HALLIE UTLEY) | $16,200 | 4% | 2 | Mar 15, 2022 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| BRISTOL MYERS SQUIBB COMPANY | $16,200 | 4% | 2 | Mar 15, 2022 |
| CSL BEHRING | $16,200 | 4% | 2 | Aug 2, 2022 |
| EISAI, INC | $16,200 | 4% | 2 | Mar 15, 2022 |
| ELI LILLY AND COMPANY | $16,200 | 4% | 2 | Mar 15, 2022 |
| GENETECH, INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| GILEAD SCIENCES INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| IPSEN BIOPHARMACEUTICALS, INC. | $16,200 | 4% | 2 | Jul 11, 2022 |
| JOHNSON & JOHNSON | $16,200 | 4% | 2 | Mar 15, 2022 |
| LUNDBECK INC | $16,200 | 4% | 2 | May 10, 2022 |
| MERCK & CO., INC. | $16,200 | 4% | 2 | Aug 2, 2022 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16,200 | 4% | 2 | Mar 15, 2022 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| PFIZER INC. | $16,200 | 4% | 2 | May 10, 2022 |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS ASSN OF AMERICA | $16,200 | 4% | 2 | Feb 8, 2022 |
| SANOFI-AVENTIS | $16,200 | 4% | 2 | May 10, 2022 |
| SUNOVIAN, INC. | $16,200 | 4% | 2 | May 10, 2022 |
| TAKEDA PHARMACEUTICALS | $16,200 | 4% | 2 | Mar 15, 2022 |
| UCB PHARMA, INC. | $16,200 | 4% | 2 | Mar 15, 2022 |
| GLAXOSMITHKLINE | $8,100 | 2% | 1 | May 10, 2022 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.